Journal Publications 


Stein M, Lipman-Arens S, Oved K, Cohen A, Bamberger E, Navon R, Boico O, Friedman T, Etshtein L, Paz M, Gottlieb TM, Kriger O, Fonar Y, Pri-Or E, Yacobov R, Dotan Y, Hochberg A, Grupper M, Chistyakov I, Potasman I, Srugo I, Eden E, Klein A


Diagn Microbiol Infect Dis. 2018 Mar;90(3):206-213. doi: 10.1016/j.diagmicrobio.2017.11.011

LRTI MS paper pic.PNG

Srugo I, Klein A, Stein M, Golan-Shany O, Kerem N, Chistyakov I, Genizi J, Glazer O, Yaniv L, German A, Miron D, Shachor-Meyouhas Y, Bamberger E, Oved K, Gottlieb TM, Navon R, Paz M, Etshtein L, Boico O, Kronenfeld G, Eden E, Cohen R, Chappuy H, Angoulvant F, Lacroix L, Gervaix A

Pediatrics. 2017 Oct;140(4). pii: e20163453. doi: 10.1542/peds.2016-3453

Pediatrics pic.PNG

Oved K, Cohen A, Boico O, Navon R, Friedman T, Etshtein L, Kriger O, Bamberger E, Fonar Y, Yacobov R, Wolchinsky R, Denkberg G, Dotan Y, Hochberg A, Reiter Y, Grupper M, Srugo I, Feigin P, Gorfine M, Chistyakov I, Dagan R, Klein A, Potasman I, Eden E.

PLoS One. 2015 Mar 18;10(3):e0120012. doi: 10.1371/journal.pone.0120012

Curiosity pic.PNG



ECCVID 2020 - Virtual Conference

Correlation of a Novel Host Biomarker, TRAIL, with ARS-CoV-2 Positivity and its Potential to Stratify COVID-19 Disease Severity


eposter snapshot.png

ID week 2018 - San Francisco, USA

Using the host immune response to identify viral-bacterial coinfection in children with respiratory syncytial virus infection.

Oral presentation

A host-response assay distinguishes between simple influenza patients and patients with bacterial coinfection.

RSV coinfection.PNG
Influenza coinfection.PNG

ECCMID 2018 - Madrid, Spain

Evaluating performance and utility of a novel host-protein assay in mild acute infections.
Oral presentation



abstract screen shot.PNG

ESPID 2018  Malmo, Sweden

Determining viral etiology: TRAIL biomarker levels and molecular viral detection in the AutoPilot-Dx study.

MeMed_e-poster picture.PNG

TRAIL, IP-10, CRP, and ImunnoXpert™ levels in children with acute respiratory tract infections - an interim analysis from the AutoPilot-Dx study.

Tobias_e-poster picture.PNG

Evaluating the potential clinical utility of a host-protein signature for distinguishing between bacterial and viral disease in febrile children.

MeMed_e-poster Rosetta.PNG

ESPID 2017 - Madrid, Spain

Evaluating a novel host-immune based assay for distinguishing bacterial from various viral infections in febrile children.

Selected best e-poster presentation

ECCMID 2017 - Vienna, Austria

Double-blind validation in febrile children of host-protein assay [TRAIL, IP-10, CRP] for distinguishing bacterial and viral infections.

Adoption of a novel host-protein signature in the workflow of acute febrile illnesses at Hillel Yaffe medical center.

AACC 2017 - San Diego, USA

Evaluating a novel host immune-based assay for distinguishing bacterial from various viral infections in febrile children.

ID Week 2017 - San Diego, USA

A novel host-protein assay accurately distinguishes bacterial from viral upper respiratory tract infections.

Molecular Dx Europe - Lisbon, Portugal

Redefining the set of solutions for antibiotics misuse using host response-based diagnostics.

A podcast by Dr. Kfir Oved

ECCMID 2016 - Amsterdam, Netherlands

A novel host-protein signature outperforms standard
laboratory parameters in the differential diagnosis of lower respiratory tract infections.

DLD Conference 2016 - Munich, Germany

When The Drugs Don´t Work

Pioneer Eran Eden and his MeMed team from Israel invented the impossible – a bloodtest that tells you if you are suffering from a bacterial or a viral infection and whether you should be treated with antibiotics or a simple chicken soup.

ID Week 2016 - New Orleans, USA

TNF-related apoptosis-inducing ligand (TRAIL) protein as a marker for disease severity in patients with acute infection.

A Novel Immunoassay that distinguishes between Bacterial and Viral Infections Based on a Patient’s Immune Response.

Distinguished abstract award

AACC 2015 - Atlanta, USA

ID Week 2015 - San Diego, USA

A Novel Host-Protein Signature Outperforms Standard Laboratory Parameters in Differential Diagnosis of Acute Infection Etiology of Febrile Children.

EuroMedLab 2015 - Paris, France

Automated ELISA measurements of host-immune biomarkers for distinguishing between acute bacterial and viral infections.

ICAAC 2015 - San Diego, USA

Validation of a novel host response based assay for diagnosis of acute infectious etiology in febrile children: a blinded retrospective observational study.



ESPID 2015 - Leipzig, Germany

Combining viral- and bacterial-induced host proteins for diagnosing serious bacterial infections in febrile children.

WSPID 2015 - Rio de Janeiro, Brazil

Mapping the co-occurrence of bacteria and viruses in healthy and febrile children.

ESPID 2014 - Dublin, Ireland

A novel host-proteome signature to distinguish between acute bacterial and viral infections in febrile children.